Listed pharmacy PK: Dashenlin is the most profitable, Yifeng has the fastest growth rate...

▍Edit: Chen Yu

Yiwen distinguishes six major listed pharmacies: Yixintang has the most stores, Dashenlin is the most profitable, the people cover the most, and Yifeng has the fastest growth rate.
.
.

Yixintang has the largest number of stores, the first to exceed 8,000

A few days ago, domestic listed drugstores have successively released 2021 semi-annual reports
.
In the wave of accelerating store expansion, Dashenlin, Yifeng, and Yixintang each had a net increase of over 800 stores in the first half of the year

Among them, ginseng forest increased the most, reaching 958; Yixintang took the lead in breaking through the 8,000 mark, becoming the chain pharmacy with the largest number of stores in China; "Shandong No.
1 Brother" Shuyu Civilian also added a net increase of 274 stores in the first half of the year, reaching a total of 2,000.
Home
.

With the increase in industry concentration and the successive listings of large national and regional pharmaceutical retail chain companies, it is bound to rely on capital to continue to build new businesses, acquire mergers and acquisitions, and carry out chain expansion
.
At the same time, small and medium chain stores and single drugstores are also reducing procurement costs by forming procurement alliances and using Internet channels, or joining leading companies to rely on their development

The number of members of the common people is the largest, reaching 57.
15 million

While expanding stores, major chains are also promoting the construction of member communities
.
The common people’s pharmacy, the second largest in the country, has the broadest membership group.

Providing members with in-depth service projects, optimizing new media operations and content operations, and optimizing the new retail system will become a new curve for the future growth of pharmacies
.

For example, Yifeng Pharmacy is actively promoting chronic disease management, online diagnosis and treatment, and online and offline health butler and family doctor services, and is committed to providing member-centered omni-channel, full-scene, and full-life-cycle health management.

.
As of the end of the reporting period, Yifeng Pharmacy had a total of 46.

Largest ginseng forest has the highest revenue and Yifeng has the fastest growth rate

With a dense network of stores and a huge member community, Lao People, Yifeng Pharmacy and Yixintang each had an operating income of more than 6 billion yuan in the first half of the year

Among them, Dashenlin completed 8.

Compared with the same period of the previous year, Yifeng Pharmacy’s revenue growth rate was the highest among the six.

Carrying out omni-channel service construction is also one of the important ways to increase revenue.

The big ginseng forest makes the most money, and the gross profit of Chinese and Western patent medicines is low

While achieving the most revenue, Dashenlin is also the most profitable drugstore among the six major chains.

For pharmacies, it has never been Chinese and Western patented medicines that have high gross profit margins

Taking the common people and Dashenlin as examples, the gross profit margins of both Chinese and Western patent medicines are about 30%, while in the traditional Chinese medicine products, the gross profit margins of the common people and Dashenlin are 49.

Based on net profit and operating income, Cyberlan-pharmacy managers calculated the net profit margins of the six major chain pharmacies in the first half of 2021.

Dashenlin, which produces decoction pieces of traditional Chinese medicine, ginseng tonic, and Chinese and Western patent medicines as one of its main businesses, has become the only company with a net profit margin of “8”; The interest rate has also reached 7.
82%
.

The common people's medical insurance stores accounted for the highest proportion, reaching 89.
37%

In terms of obtaining the qualifications of "Medical Insurance Designated Retail Pharmacies", the situation of the six major chain pharmacies is similar, with qualified stores accounting for more than 80% of the total number of stores directly operated by the company
.

For retail pharmacies, including designated retail pharmacies at the national level into the coverage of medical insurance drugs, and implementing a unified payment policy with medical institutions, is a major policy advantage.
It can not only expand the sales of prescription drugs, but also promote the specialty of retail pharmacies.
The level of chemistry has improved
.

Conclusion: 2021 is the first year of China’s 14th Five-Year Plan.
With the advent of the post-epidemic era, the people are paying more and more attention to health, preventive demand is growing, Internet + medical insurance payment, national medical insurance negotiation drugs "dual channel", etc.
Policies have also been implemented one after another, and the development of retail pharmacies is facing new challenges as well as new opportunities
.